ClinicalTrials.Veeva

Menu

Community Health Worker And MHealth to ImProve Viral Suppression (CHAMPS)

Columbia University logo

Columbia University

Status

Completed

Conditions

HIV/AIDS

Treatments

Behavioral: CHW Sessions
Device: Wise App with medication adherence reminders

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04562649
R01NR019758 (U.S. NIH Grant/Contract)
AAAT2430

Details and patient eligibility

About

The overall goal of this study is to evaluate the effects of the CHAMPS intervention for people living with HIV (PLWH) in a randomized controlled trial. The proposed trial is scientifically significant in representing a principled and systematic effort to test the efficacy of a combined community health worker (CHW) and smartphone intervention linked to a smart pill box for antiretroviral (ART) adherence in PLWH in the United States (US). Guided by a rigorous theoretical model of supportive accountability and building on preliminary work, this intervention has the potential to enable PLWH to self-manage their ART regimens while CHW monitor their ART adherence in real-time ultimately leading to viral suppression and ART adherence.

Full description

Persons living with HIV (PLWH) now achieve a near-normal life expectancy due to antiretroviral therapy (ART) which has transformed HIV from a terminal diagnosis to a manageable chronic condition. Despite widespread availability of ART in the United States (US), many of the country's approximate 1.1 million PLWH are not fully benefitting from ART due to poor adherence. These suboptimal HIV health outcomes occur at a time when clinicians have limited time and the US healthcare system remains fragmented, further exacerbating the challenges inherent in the lives of underserved, marginalized groups, such as PLWH. Therefore, the development and evaluation of interventions using a cadre of community health workers (CHW) holds promise for addressing these challenges in the US. This study addresses limitations in current research on CHW interventions to improve viral suppression and ART adherence. The investigators propose to build on strong preliminary data to strengthen a community health worker (CHW) intervention using an existing mHealth approach, and provide further information regarding the successful wide-scale implementation of this combination intervention.

Enrollment

300 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be able to communicate and read in English or Spanish
  • Willing to participate in any assigned arm of the intervention
  • Diagnosed with HIV ≥6 months ago
  • Have an HIV-1 RNA level >200 copies/mL, or have at least one "no-show" visit in the past 12 months, or report being virally unsuppressed in the past 12 months
  • Have ART adherence <80%, as measured through Single-Item Self-Rating Adherence Scale (SRSI)
  • Own a smartphone

Exclusion criteria

  • Reside in a nursing home, prison, and/or receiving in-patient psychiatric care at time of enrollment
  • Terminal illness with life expectancy <6 months
  • Planning to move out of the area in the next 12 months

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

300 participants in 2 patient groups

Intervention
Experimental group
Description:
Wise App that delivers medication adherence reminders and community health worker sessions
Treatment:
Device: Wise App with medication adherence reminders
Behavioral: CHW Sessions
Control
No Intervention group
Description:
Standard of care

Trial documents
2

Trial contacts and locations

3

Loading...

Central trial contact

Rebecca Schnall, PhD, MPH, RN; Olivia Wood

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems